61°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Community Choice

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeuroSense Therapeutics Ltd. - Ordinary Shares (NQ:NRSN)

0.8046 +0.0996 (+14.13%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeuroSense Therapeutics Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >

Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics' Lead Drug Candidate, PrimeC ↗

October 18, 2023

Induced pluripotent stem cells (iPSCs) have emerged as a promising tool in the field of research and therapy for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS). ALS is a...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 29, 2023

Friday's session saw 112 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 17, 2023 ↗

July 17, 2023

Via Benzinga

Why Is NeuroSense (NRSN) Stock Up 35% Today? ↗

June 30, 2022

NRSN stock is on the move in the wake of encouraging clinical results for a novel drug combination to treat Alzheimer's disease.

Via InvestorPlace

Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket ↗

January 23, 2023

Gainers Jeffs' Brands Ltd (NASDAQ: JFBR) rose 76.5% to $2.70 in pre-market trading after jumping 19% on Friday.

Via Benzinga

Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 20, 2023

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.

Via Benzinga

NeuroSense Shares Surge On Encouraging Data From Alzheimer's-Associated Biomarker Study ↗

June 30, 2022

Via Benzinga

Dow Drops 50 Points; Netflix Sales Top Estimates ↗

January 20, 2023

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Friday.

Via Benzinga

Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket ↗

January 20, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 20, 2023

It's the final day of trading this week and we're checking in on the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

Dow Drops 150 Points; Crude Oil Up 1% ↗

January 19, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 150 points on Thursday.

Via Benzinga

Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 19, 2023

Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.

Via Benzinga

Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings ↗

January 19, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 300 points on Thursday.

Via Benzinga

NeuroSense Therapeutics (NASDAQ: NRSN) Shares Positive Final Results From Alzheimer’s Disease Biomarker Study

January 19, 2023

NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN) is a clinical-stage biotechnology company, which is focused on the research and development of treatments

Via Spotlight Growth

Why Is NeuroSense (NRSN) Stock Up 98% Today? ↗

January 19, 2023

NeuroSense (NRSN) stock is taking off on Thursday as investors react to data from a biomarker study concerning Alzheimer's disease (AD).

Via InvestorPlace

Why Investors Are Buying NeuroSense Therapeutics Stock Today ↗

January 19, 2023

Shares of clinical-stage biotech company NeuroSense Therapeutics Ltd (NASDAQ: NRSN) are ripping higher Thursday morning after the company reported positive final results from its

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 16, 2022

Pre-market stock movers are a hot topic among traders this morning as we cover all of the biggest news moving shares on Wednesday!

Via InvestorPlace

Stocks That Hit 52-Week Lows On Thursday ↗

December 29, 2022

On Thursday, 116 companies set new 52-week lows.

Via Benzinga

Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday's Mid-Day Session ↗

July 06, 2022

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change...

Via Benzinga

Coinbase, Moderna And 56 Biggest Movers From Yesterday ↗

July 07, 2022

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 06, 2022

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers for investors to keep an eye on today!

Via InvestorPlace

Why Is SCWorx Jumping By Around 36%? 20 Stocks Moving In Wednesday's Pre-Market Session ↗

July 06, 2022

Gainers Hexo Corp (NYSE: HEXO) rose 106.8% to $0.43 in pre-market trading. HEXO’s shareholders, on Tuesday, approved the note transaction with Tilray Brands.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Nasdaq Down 100 Points; Angion Biomedica Shares Plummet ↗

June 30, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.

Via Benzinga

Dow Drops 250 Points; Rapid Micro Biosystems Shares Spike Higher ↗

June 30, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Thursday.

Via Benzinga

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session ↗

June 30, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...

Via Benzinga

Why U.S. Stocks Are Trading Sharply Lower, Jobless Claims Report And More ↗

June 30, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 450 points on Thursday.

Via Benzinga

Aspen Aerogels And 28 Stocks Moving Premarket ↗

June 30, 2022

Gainers

Via Benzinga

Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session ↗

June 28, 2022

Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating...

Via Benzinga

Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027

June 28, 2022

Palm Beach, FL – June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent...

Via FinancialNewsMedia

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

NeuroSense Therapeutics Ltd. - Ordinary Shares (NQ:NRSN)

All News about NeuroSense Therapeutics Ltd. - Ordinary Shares

Sections

Services